(Q44277341)

English

Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism.

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

based on heuristic

inferred from title

Carsten Uhd Nielsen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Bente Steffansen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Anne Engelbrecht Thomsen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Gerda Marie Friedrichsen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Arne Hagsten Sørensen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Rikke Andersen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Mikael Begtrup

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Sven Frokjaer

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Journal of Controlled Release

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

86

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

279-292

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12526824%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability, metabolism and transport of D-Asp(OBzl)-Ala--a model prodrug with affinity for the oligopeptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Model prodrugs for the intestinal oligopeptide transporter: model drug release in aqueous solution and in various biological media.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of Dihydroisoxazole Nucleoside and Nucleotide Analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

N-vinyl derivatives of substituted pyrimidines and purines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Model prodrugs designed for the intestinal peptide transporter. A synthetic approach for coupling of hydroxy-containing compounds to dipeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diketopiperazine formation, hydrolysis, and epimerization of the new dipeptide angiotensin-converting enzyme inhibitor RS-10085.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Preformulation stability studies of the new dipeptide angiotensin-converting enzyme inhibitor RS-10029

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification and characterization of a rat liver enzyme that hydrolyzes valaciclovir, the L-valyl ester prodrug of acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900413-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44277341&oldid=2109085040"